NFKB1 and autoimmune disease: In addition to NF-κB, p38 MAPK enzyme is known to be involved in cell proliferation and cytokine secretion and several p38 MAPK inhibitors are being developed for possible therapeutic effect on autoimmune diseases and inflammatory processes (Goldstein and Gabriel 2005).